Oncology Nutrition Market by Nutrition Support (Enteral and Parenteral Nutrition), Type of Cancer (Head & Neck Cancer, Gastrointestinal, Esophageal, Pancreatic, Liver and Blood Cancer) and Geography- Global market share, Trend Analysis and Forecast

Cancer has always been one of the most threatening diseases in the world with a high chance of mortality. The oncology nutrition field principally focuses on personalized nutrition plans to help patients deal with the unique challenges of their illness and treatment plan. Nutritional oncology is an increasingly active interdisciplinary field, playing an important role in improving bodily resources, tolerance of cancer treatments, and the overall quality of life. Oncology nutrition persists to stay imperative area of focus for healthcare providers attributed to constant in the number of cases of malnutrition induced by tumours worldwide.  For instance, According to World Health Organisation, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018.

Oncology Nutrition Market Driving Factors 

• Increasing cases of cancer disease and increasing requirement to meet the nutritional demands during treatment are the major key factors, driving the growth of the market. For instance, According to WHO, every sixth death in the globe is because of cancer, which makes it the second most common cause of death. In 2017, 9.6 million people are projected to have died from the different forms of cancer. 
• Malnourishment, caused because of malignant growth treatment or other related intricacies, can make patients weak. Besides, it might prompt interruptions or deferrals in the cancer treatment. On the other hand, consuming excessive calories could prompt weight gain, thusly, expanding the danger of cancer reoccurrence. As per Cancer Treatment Centres of America (CTCA), roughly 65 to 70% of oncology patients experience the malnutrition. To deal with such situations, the demand of oncology nutrition is increasing 
• In addition, increasing awareness programs in developing countries regarding benefits of nutritional requirements are also boosting the market.

Oncology Nutrition Market Key Developments 

January 2020: Swiss food giant Nestle bulked up its medical nutrition business by purchasing Allergan’s (AGN.N) Zenpep, a product for people whose pancreases do not provide enough enzymes to properly digest fats, proteins and sugars.

September 2019. Smartfish AS has initiated a strategic collaboration with the global healthcare company B. Braun to secure a global launch of its medical nutrition product Remune. B. Braun will launch Remune in close to 20 countries during 2019 and 2020, followed by several other markets in Europe, Asia and South America.                    

Oncology Nutrition Market Segmental Highlights

The report analyses the global Oncology Nutrition market based on nutrition, type of cancer and geography. 

• Based on the nutrition support type, the oncology nutrition market is categorised into enteral and parenteral nutrition. The enteral nutrition type represents the dominant position in oncology nutrition market.  Enteral nutrition is preferred for patients with a functioning gastrointestinal tract because it is more physiological, entails fewer complications and is comparatively less expensive than parenteral nutrition. Moreover, the enteral administration supports lowers the risk of infection and contamination. 
• Oncology nutrition market finds application in Head & Neck Cancer, Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer and Blood Cancer etc. Patients with head and neck cancer face unique challenges in maintaining adequate nutrition. Both the disease itself and the treatments, especially surgery and radiation therapy, have significant negative impact on upper digestive tract function and oral intake is often insufficient during and after therapy. Thus, there is large demand of the oncology nutrition in the treatment of head and neck cancer.
• The oncology nutrition market is studied for the key regions including North America, Europe, Asia Pacific, and Rest of the World. The North America region dominated the global oncology nutrition market. The large share of North America can be attributed to the high adoption of oncology nutrition among the aging population, increasing prevalence of cancer, the presence of many large hospitals. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment. 

Oncology Nutrition Market Key Players 

Key players in the global oncology nutrition market include Eurofins Scientific, Charles River Laboratories International, Becton, Dickinson and Company, SGS, Merck KGaA, bioMérieux, Pacific Biolabs, WuXi AppTec, North American Science Associates, and American Type Culture Collection among others.